Crunchbase, a leading business information platform, offers real-time data on startups, investors, and funding rounds. Trusted globally, it empowers professionals with insights for strategic decision-making and market analysis.
Merck pledges nearly $2 billion to acquire an oral lipid-lowering drug from a Chinese biotech, aiming to expand its cardiovascular portfolio and address global cholesterol management needs.